Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil A Marshall

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Pharmacology|April 20, 2011
TLR based therapeuticsAisling Dunne, Neil A Marshall, Kingston H G Mills
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1Neil A Marshall, Mark A Vickers, Robert N Barker
Blood|February 29, 2008
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphomaSajjan Mittal, Neil A Marshall, Linda Duncan, et al.
Experimental Hematology|March 24, 2007
The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphomaNeil A Marshall, Dominic J Culligan, Jane Tighe, et al.
British Journal of Haematology|September 15, 2007
CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remissionNeil A Marshall, Dominic J Culligan, Peter W Johnston, et al.
Cancer Research|December 14, 2011
Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumorsNeil A Marshall, Karen C Galvin, Anna-Maria B Corcoran, et al.
Blood|November 8, 2003
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphomaNeil A Marshall, Linsey E Christie, Laura R Munro, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2013
Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cellsKaren C Galvin, Lydia Dyck, Neil A Marshall, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Pharmacology|April 20, 2011
TLR based therapeuticsAisling Dunne, Neil A Marshall, Kingston H G Mills
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1Neil A Marshall, Mark A Vickers, Robert N Barker
Blood|February 29, 2008
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphomaSajjan Mittal, Neil A Marshall, Linda Duncan, et al.
Experimental Hematology|March 24, 2007
The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphomaNeil A Marshall, Dominic J Culligan, Jane Tighe, et al.
British Journal of Haematology|September 15, 2007
CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remissionNeil A Marshall, Dominic J Culligan, Peter W Johnston, et al.
Cancer Research|December 14, 2011
Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumorsNeil A Marshall, Karen C Galvin, Anna-Maria B Corcoran, et al.
Blood|November 8, 2003
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphomaNeil A Marshall, Linsey E Christie, Laura R Munro, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2013
Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cellsKaren C Galvin, Lydia Dyck, Neil A Marshall, et al.
Pageof 1